Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, December 12, 2023
[ Tue, Dec 12th 2023
] - WOPRAI
[ Tue, Dec 12th 2023
] - WOPRAI
[ Tue, Dec 12th 2023
] - WOPRAI
[ Tue, Dec 12th 2023
] - WOPRAI
[ Tue, Dec 12th 2023
] - WOPRAI
[ Tue, Dec 12th 2023
] - WOPRAI
[ Tue, Dec 12th 2023
] - WOPRAI
[ Tue, Dec 12th 2023
] - WOPRAI
[ Tue, Dec 12th 2023
] - WOPRAI
[ Tue, Dec 12th 2023
] - WOPRAI
[ Tue, Dec 12th 2023
] - WOPRAI
[ Tue, Dec 12th 2023
] - WOPRAI
[ Tue, Dec 12th 2023
] - WOPRAI
[ Tue, Dec 12th 2023
] - WOPRAI
[ Tue, Dec 12th 2023
] - WOPRAI
[ Tue, Dec 12th 2023
] - WOPRAI
[ Tue, Dec 12th 2023
] - WOPRAI
[ Tue, Dec 12th 2023
] - WOPRAI
[ Tue, Dec 12th 2023
] - WOPRAI
[ Tue, Dec 12th 2023
] - WOPRAI
Mon, December 11, 2023
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
Chris Shibutani Upgraded (ABBV) to Strong Buy and Held Target at $173 on, Dec 11th, 2023
Chris Shibutani of Goldman Sachs, Upgraded "AbbVie Inc." (ABBV) to Strong Buy and Held Target at $173 on, Dec 11th, 2023.
Chris has made no other calls on ABBV in the last 4 months.
There are 4 other peers that have a rating on ABBV. Out of the 4 peers that are also analyzing ABBV, 1 agrees with Chris's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- James Shin of "Deutsche Bank" Initiated at Hold and Held Target at $150 on, Thursday, November 9th, 2023
These are the ratings of the 3 analyists that currently disagree with Chris
- Gary Nachman of "Raymond James" Maintained at Buy with Increased Target to $181 on, Friday, December 1st, 2023
- Terence Flynn of "Morgan Stanley" Maintained at Buy with Increased Target to $196 on, Monday, October 30th, 2023
- Carter Gould of "Barclays" Upgraded from Hold to Buy and Increased Target to $170 on, Monday, October 30th, 2023
